{"entity":{"id":"src-fierce-biotech","kind":"collection","name":"Fierce Biotech","aka":[],"tldr":"Fierce Biotech is where trial failures get reported plainly.","summary":"Fierce Biotech is industry news with a dedicated oncology channel, covering trial failures and successes, layoffs and financings, and it is where trial failures get reported plainly. It is published daily by Questex and is free with registration. Because it reports the failures as directly as the successes, it is a useful counterweight to company announcements and to news outlets that lead only with positive readouts. On OnCo it is listed as a source with the tags source and news, read for the industry side of oncology.","asOf":"2026-09-08","links":[{"label":"Fierce Biotech","url":"https://www.fiercebiotech.com/"}],"tags":["source","news"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"url":"https://www.fiercebiotech.com/","holds":"Industry news with an oncology channel: trial failures and successes, layoffs, financings.","license":"Free with registration","maintainer":"Questex"},"route":"/collections/src-fierce-biotech/","neighbours":{"company":[{"id":"aktis-oncology","kind":"company","name":"Aktis Oncology","route":"/companies/aktis-oncology/"},{"id":"kymera","kind":"company","name":"Kymera Therapeutics","route":"/companies/kymera/"},{"id":"nkarta","kind":"company","name":"Nkarta","route":"/companies/nkarta/"}]}}